STOCKWATCH
·
Pharmaceuticals
USFDA26 Aug 2025, 02:53 pm

Unichem Laboratories Receives EIR from USFDA for Roha API Facility

AI Summary

Unichem Laboratories Limited has announced that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for its Roha API facility. This announcement comes after the USFDA conducted an inspection at the facility from 16th June 2025 to 20th June 2025. The USFDA has classified the inspection as Voluntary Action Initiated (VAI).

Key Highlights

  • Unichem Laboratories Limited has received the Establishment Inspection Report (EIR) from the USFDA for its Roha API facility.
  • The USFDA conducted an inspection at the facility from 16th June 2025 to 20th June 2025.
  • The USFDA has classified the inspection as Voluntary Action Initiated (VAI).
UNICHEMLAB
Pharmaceuticals
UNICHEM LABORATORIES LTD.

Price Impact